We studied the regulation of fibronectin ( 
Introduction
The expression of fibronectin (FN), an adhesive glycoprotein present in the extracellular matrix, is of great importance in development, wound healing, fibrogenesis, and neoplastic transformation (For reviews, see Hynes, 1990) . A number of factors have been reported to regulate FN expression. These include transforming growth factor-β, glucocorticoids, viral proteins such as HTLV-I Tax and adenovirus E1A, and transcription factors such as E2F1 (Dean et al. , 1988; Nakajima et al., 1992; Taylor et al., 1992; Jordan-Sciutto et al., 1997) . The cAMP pathway has been shown to be an important signaling pathway involved in FN expression (Dean et al. , 1988 (Dean et al. , , 1989 . It has been reported to activate the transcription of FN gene through the cAMP-responsive element (CRE) in FN promoter (Dean et al., 1989; Bowlus et al., 1991) . The protein kinase C (PKC) pathway, another important signaling pathway, has also been shown to regulate FN expression (Cagliero et al., 1991; Studer et al., 1993; Lee et al., 1996) .
Regulation of FN expression by cAMP and PKC pathways show different patterns depending on cell type. Cyclic AMP stimulates FN synthesis in fibrosarcoma cells but inhibits it in granulosa cells (Dean et al., 1988; Dean et al., 1989; Bernath et al., 1990) . Phorbol-12-m y r i s t a t e -1 3 -acetate (PMA), a PKC activator, stimulates FN expression in lung fibroblasts and renal mesangial cells but inhibits it in endothelial cells (Cagliero et al., 1991; Studer et al., 1993; Lee et al., 1996) . These reports suggest cell-type specific regulation of FN expression. In addition, cAMP and PKC pathways show synergistic or antagonistic interactions in the regulation of the expression of cellular genes including the FN gene. Cyclic AMP and PMA interact synergistically to regulate the expression of the chorionic gonadotropin gene in choriocarcinoma cells (Anderson et al., 1988) . Cyclic AMP inhibits the PKC-induced stimulation of FN expression in human lung fibroblasts, while it alone has no effect (Lee et al., 1997) . In this regard, we studied the regulation of FN gene expression by cAMP and PMA and their interaction in HT-1080 human fibrosarcoma cells in which FN expression has been reported to be induced by cAMP (Dean et al., 1988; Dean et al., 1989) .
(BSA) and the indicated reagents. The cell layer FN was extracted using a lysis buffer containing 10 mM Tr i sHCl, pH 7.4, 0.15 M NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.5% SDS, 1 mM EDTA and 1 mM PMSF. The total amount of FN in the medium and cell layer was determined by ELISA and then normalized by the cellular DNA content measured by fluorophotometric assay as described previously (Kim e t a l ., 1992) . Microtiter plates were coated with 100 ng of purified human plasma FN. The first antibody was a 1:800 dilution of goat anti-human FN antibody (Sigma). The second antibody was a 1:3,000 dilution of horseradish peroxidase-conjugated rabbit anti-goat IgG (Sigma). The enzyme substrate was ophenylenediamine, and the absorbance was read at 492 nm. The standard curve using purified human plasma FN was linear between 30 ng and 300 ng.
Radioactive labeling and immunoprecipitation of FN
Confluent cells in 35-mm culture dishes were incubated with serum-free MEM containing 1% BSA and reagents and then labeled for 2 h with methionine-free MEM containing 30 µCi/ml [ 3 5 S]methionine (Amersham) and the corresponding reagents. The medium was collected and the cell layer FN was extracted with a lysis buffer as described above. Immunoprecipitation of FN from the combined samples of medium and cell layer extracts containing equal amounts of radioactive total protein was performed as described previously (Lee e t a l ., 1996) . An excess (3 µg) of goat anti-human FN antibody was added to the combined samples of medium and cell layer extracts containing the same amounts of radioactivity and then incubated at 4˚C for 1-2 h. The immune complexes were incubated with 30 µl of protein A-sepharose beads (Pharmacia) for 1 hour. Sepharose beads and adsorbed proteins were solubilized in 30 µl of an electrophoresis sample buffer by heating at 100˚C for 4 min. Samples containing the isolated FN were analyzed either by S D S -PAGE using a 6% gel and subsequent fluorography or by counting the radioactivity (cpm) of the solution with a β-counter.
Northern blot hybridizations
Confluent cells in 100-mm culture dishes were incubated with serum-free MEM containing 1% BSA and reagents. Total cellular RNA was isolated with acid guanidinium thiocyanate-phenol-chroloform, fractionated by electrophoresis on a 0.8% agarose gel containing 2.2 M formaldehyde, transferred to a nylon membrane, and hybridized with a cDNA probe as described previously (Sambrook et al., 1989) . The cDNA probe was labeled with [α-32 P] dCTP (Amersham) using a megaprime DNA labeling system (Amersham). FH1 human FN cDNA (Kornblihtt et al., 1983) and pHcGAP human glyceraldehyde-3-phosphate dehydrogenase cDNA (Tso et al., 1985) were used as probes.
Plasmid constructions
To construct the plasmid pGL2F1900 containing DNA sequences from -1908 to +136 of the rat FN gene fused to the luciferase reporter gene, the plasmid pF1900CAT containing the same DNA sequences fused to the CAT gene (provided by Dr. Kinichiro Oda, Science University of Tokyo) was cleaved with P s tI. The 2.1 kb P s tI fragment of the FN gene was inserted into the PstI site of pBluescript II KS(-) (Stratagene) to generate pBS-F1900. Finally, the insert was cleaved with BamHI-HindIII from pBS-F1900 and inserted into the B g lI I-H i n dIII site of pGL2-Basic vector (Promega) to generate pGL2F1900.
Transient and stable transfection of DNA
DNA transfection was performed by using the CaPO 4 precipitation method modified by Chen and Okayama (Chen and Okayama, 1987) . Cells (4 1 0 5 cells per dish) were plated the day before transfection onto 100-mm culture dishes and grown to an approximate 70% confluence. Cells were transfected with 4 µg of pGL2F 1900, 1 µg of pSV β-gal as an internal control, and 3 µg of pGL2-Basic vector as a carrier. After incubation with the DNA precipitate for 5 h and subsequently with 15% glycerol for 2 min, cells were recovered overnight with a fresh medium containing 10% serum. Cells were then incubated with each reagent in a medium containing 0.5% serum for 24 h and harvested at 48 h from the start of transfection. For stable transfection, cells grown in 60-mm culture dishes were transfected with 7 µg of pGL2F1900, 0.7 µg of pSVβ-gal, and 0.7 µg of pSVNeo as a selection marker. Transfected clones were selected by subculture in a medium containing 400 µg/ml of geneticin (GIBCO/BRL). All selected clones were pooled and used for the following experiments.
Luciferase and -galactosidase assays
Cells were lysed with 250 µl of a lysis solution (100 mM potassium phosphate, pH 7.8, 0.2% (v/v) Triton X-100, and 1 mM dithiothreitol (DTT)). For luciferase assays, 100 µl of the cell lysates were mixed with 500 µl of a luciferase assay buffer (15 mM potassium phosphate, pH 7.8, 25 mM glyglycine, pH 7.8, 15 mM MgSO 4 , 4 mM E G TA, 2 mM AT P, and 1 mM DTT). The reaction mixture was incubated with 100 µl of a luciferase assay b u ffer containing 100 µM luciferin (Analytical luminescence laboratory) and luminescence was measured by using a luminometer (Berthold). For β-galactosidase assays, 10 µl of the cell lysates were used and activity was measured with a Galacto-Light™ chemiluminesent reporter assay system (Tr o p i x ) according to the manufacturer's directions.
Results
Treatment of HT-1080 cells for 24 h with dibutyryl cAMP (Bt 2 cAMP), a cAMP analogue, increased FN synthesis in a dose-dependent manner with a maximum 3.5-fold increase, whereas treatment with PMA, a PKC activator, did not affect FN synthesis at any concentration tested ( Figure 1A) . To examine the time-course of FN synthesis, cells were treated for various periods of time with either 1 mM Bt 2 cAMP or 100 ng/ml PMA. Bt 2 cAMP increased FN synthesis time-dependently from 3 hours to 48 h, while PMA did not ( Figure 1B) . The effect of these reagents on FN synthesis does not seem to be a nonspecific eff e c t on total protein synthesis, since neither Bt 2 cAMP nor PMA affect total protein synthesis (data not shown).
To study the interaction between cAMP and PMA, cells were treated for 48 h with Bt 2 cAMP and PMA in combination. PMA inhibited the Bt 2 c A M P -i n d u c e d stimulation of FN synthesis, but when used alone had no effect (Figure 2A ). To test whether the regulation by cAMP and PMA occurs at the mRNA levels, the steadystate levels of FN mRNA were determined. In agreement with the results of FN synthesis, Bt 2 cAMP increased FN mRNA levels, while PMA inhibited the Bt 2 c A M Pinduced increase of FN mRNA levels ( Figure 2B ).
To investigate the regulation of FN expression by cAMP and PMA and their interaction at the transcriptional level, the plasmid containing 1900 bp of FN promoter fused to the luciferase reporter gene was transiently transfected into HT-1080 cells. Bt 2 c A M P increased the FN promoter activity by 4.5-fold, while PMA alone did not show any significant effect ( Figure  3A) . PMA, on the contrary to its inhibitory effect on the cAMP-induced FN synthesis and mRNA levels, enhanced the cAMP-induced FN promoter activity up to 10-fold ( Figure 3A ).
Since the effect of PMA on the cAMP-induced transiently transfected promoter activity was different from that of PMA on the cAMP-induced FN synthesis and mRNA levels, stable transfection experiments were performed. H o w e v e r, neither Bt 2 cAMP nor PMA affected stably transfected FN promoter activity ( Figure 3B ). The combined treatment of PMA and Bt 2 cAMP did not affect stably transfected promoter activity, either ( Figure 3B ).
Discussion
This study shows that PMA antagonizes cAMP-induced FN gene expression and that both the induction of FN gene expression by cAMP and the inhibition of cAMP action by PMA may occur at the posttranscriptional level in H T-1080 human fibrosarcoma cells. Cyclic AMP stimulated FN synthesis and mRNA levels and the activity of a transiently transfected FN promoter, but had no effect on the activity of a stably transfected promoter. The discrepancy between the protein/mRNA levels and the promoter activity suggests that cAMP probably stimulates FN expression through posttranscriptional regulation in HT-1080 cells. PMA inhibited the cAMPinduced FN synthesis and mRNA levels but enhanced the cAMP-induced transiently transfected FN promoter, while having no effect on the stably transfected promoter.
The differential e ffect of PMA on cAMP-induced FN protein/mRNA levels and promoter activity suggests that the PMA-induced signaling pathway antagonistically interacts with the cAMP pathway in regulating FN expression probably at the posttranscriptional level in HT-1080 cells.
Synergistic or antagonistic interactions between cAMP and PMA on the FN expression depending on cell-types have been reported (Anderson et al., 1988; Lee et al., 1997) . Previously it has been shown that cAMP alone has no effect on FN expression but inhibits the PMAinduced stimulation of FN expression in lung fibroblasts (Lee et al., 1997) . The present study, on the contrary, shows that PMA alone has no effect on FN expression but inhibits the cAMP-induced stimulation of FN expression in H T-1080 fibrosarcoma cells. The mechanism of the c e l l -type specific regulation of FN expression is still u n k n o w n .
Cyclic AMP has been reported to stimulate FN expression by activating transcription possibly through the CRE site at -170 and two putative CRE-like sites at -260 and -415 in FN promoter, based on the results of transient transfection experiments in HT-1080 cells (Dean et al., 1989; Bowlus et al., 1991) . In agreement with the previous reports (Dean et al., 1989; Bowlus et al., 1991) , this study shows that cAMP stimulates the activity of transiently transfected FN promoter. This study, however, shows that cAMP has no effect on the activity of stably transfected FN promoter. Several possible explanations could be considered for the discrepancy in the promoter activity were treated with Bt2cAMP (1 mM) and PMA (100 ng/ml) for 48 h and the activities of luciferase and β-galactosidase were determined. Each bar represents promoter activity expressed relatively to the control value. Data are given as a mean ± S.D. of three different experiments.
